Tshzmachyan et al., performed a randomized control trial investigating the effect of Letrozole on OHSS rates in high-risk polycystic ovary syndrome (PCOS) patients with elevated Anti-Mullerian Hormone (AMH) undergoing short GnRH therapy. The gene discussed is AMH; the disease is ovarian hyperstimulation syndrome.